Given the central location of acetylated lysine clusters within the MTBR, we propose that acetylation, particularly at residues K280/K281 as well as other lysines that physically engage MTs, mediates loss of MT-regulatory function and gain of abnormal tau aggregation in sporadic tauopathies including AD. This evidence concerns the gene MAPT and Alzheimer disease.